nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—SLC22A8—Mercaptopurine—Crohn's disease	0.588	1	CbGbCtD
Baclofen—Drug ineffective—Mesalazine—Crohn's disease	0.0136	0.0475	CcSEcCtD
Baclofen—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.0124	0.106	CbGpPWpGaD
Baclofen—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.0124	0.106	CbGpPWpGaD
Baclofen—Pneumonia aspiration—Mesalazine—Crohn's disease	0.0108	0.0377	CcSEcCtD
Baclofen—Meningitis—Azathioprine—Crohn's disease	0.00667	0.0233	CcSEcCtD
Baclofen—Personality change—Prednisone—Crohn's disease	0.0065	0.0227	CcSEcCtD
Baclofen—Haematochezia—Mesalazine—Crohn's disease	0.00585	0.0204	CcSEcCtD
Baclofen—Faecal incontinence—Mesalazine—Crohn's disease	0.00467	0.0163	CcSEcCtD
Baclofen—Memory loss—Prednisone—Crohn's disease	0.00424	0.0148	CcSEcCtD
Baclofen—Ibuprofen—CXCL8—Crohn's disease	0.00422	0.454	CrCbGaD
Baclofen—Sepsis—Mercaptopurine—Crohn's disease	0.00377	0.0132	CcSEcCtD
Baclofen—GABBR2—G alpha (i) signalling events—CCR9—Crohn's disease	0.00369	0.0315	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—ACKR2—Crohn's disease	0.0034	0.029	CbGpPWpGaD
Baclofen—Tongue disorder—Mesalazine—Crohn's disease	0.00324	0.0113	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—MLN—Crohn's disease	0.00322	0.0275	CbGpPWpGaD
Baclofen—Meningitis—Prednisone—Crohn's disease	0.00321	0.0112	CcSEcCtD
Baclofen—Albuminuria—Mesalazine—Crohn's disease	0.00316	0.011	CcSEcCtD
Baclofen—Withdrawal symptom—Prednisone—Crohn's disease	0.00304	0.0106	CcSEcCtD
Baclofen—Neoplasm malignant—Azathioprine—Crohn's disease	0.00303	0.0106	CcSEcCtD
Baclofen—Breast disorder—Mercaptopurine—Crohn's disease	0.00285	0.00995	CcSEcCtD
Baclofen—Chlorphenesin—PTGS2—Crohn's disease	0.00276	0.296	CrCbGaD
Baclofen—Musculoskeletal stiffness—Mesalazine—Crohn's disease	0.00263	0.00918	CcSEcCtD
Baclofen—Drug withdrawal syndrome—Prednisone—Crohn's disease	0.00254	0.00889	CcSEcCtD
Baclofen—Leukocytosis—Mesalazine—Crohn's disease	0.00251	0.00876	CcSEcCtD
Baclofen—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.00249	0.0212	CbGpPWpGaD
Baclofen—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.00249	0.0212	CbGpPWpGaD
Baclofen—GABBR2—G alpha (i) signalling events—CCR6—Crohn's disease	0.00244	0.0209	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—CCR9—Crohn's disease	0.00238	0.0203	CbGpPWpGaD
Baclofen—Vaginal inflammation—Mesalazine—Crohn's disease	0.00236	0.00824	CcSEcCtD
Baclofen—Phosphatase alkaline increased—Mesalazine—Crohn's disease	0.00236	0.00824	CcSEcCtD
Baclofen—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.0023	0.00803	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—CCR9—Crohn's disease	0.00223	0.0191	CbGpPWpGaD
Baclofen—Vaginal infection—Mesalazine—Crohn's disease	0.00222	0.00778	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—ACKR2—Crohn's disease	0.00219	0.0187	CbGpPWpGaD
Baclofen—Coma—Mesalazine—Crohn's disease	0.00215	0.00753	CcSEcCtD
Baclofen—Hepatic function abnormal—Azathioprine—Crohn's disease	0.00215	0.00751	CcSEcCtD
Baclofen—Bladder pain—Mesalazine—Crohn's disease	0.00213	0.00745	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—MLN—Crohn's disease	0.00208	0.0177	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—GPR65—Crohn's disease	0.00208	0.0177	CbGpPWpGaD
Baclofen—Hypertonia—Mesalazine—Crohn's disease	0.00206	0.00722	CcSEcCtD
Baclofen—Blood alkaline phosphatase increased—Mesalazine—Crohn's disease	0.00197	0.00687	CcSEcCtD
Baclofen—Gastroenteritis—Mesalazine—Crohn's disease	0.00193	0.00675	CcSEcCtD
Baclofen—Alopecia—Mercaptopurine—Crohn's disease	0.00193	0.00673	CcSEcCtD
Baclofen—Disorientation—Mesalazine—Crohn's disease	0.00191	0.00668	CcSEcCtD
Baclofen—Malnutrition—Mercaptopurine—Crohn's disease	0.0019	0.00663	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—MLN—Crohn's disease	0.00182	0.0156	CbGpPWpGaD
Baclofen—Suicidal ideation—Prednisone—Crohn's disease	0.00178	0.00621	CcSEcCtD
Baclofen—Anaemia—Mercaptopurine—Crohn's disease	0.00175	0.00613	CcSEcCtD
Baclofen—Lethargy—Mesalazine—Crohn's disease	0.00175	0.0061	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—ACKR2—Crohn's disease	0.00174	0.0149	CbGpPWpGaD
Baclofen—Osteoarthritis—Mesalazine—Crohn's disease	0.00171	0.00598	CcSEcCtD
Baclofen—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.00171	0.00598	CcSEcCtD
Baclofen—Affect lability—Mesalazine—Crohn's disease	0.00168	0.00588	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—MLN—Crohn's disease	0.00165	0.0141	CbGpPWpGaD
Baclofen—Face oedema—Mesalazine—Crohn's disease	0.00165	0.00577	CcSEcCtD
Baclofen—Mood swings—Mesalazine—Crohn's disease	0.00162	0.00566	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.0016	0.00561	CcSEcCtD
Baclofen—Memory impairment—Prednisone—Crohn's disease	0.00159	0.00555	CcSEcCtD
Baclofen—GABBR1—G alpha (i) signalling events—CCR6—Crohn's disease	0.00157	0.0135	CbGpPWpGaD
Baclofen—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00156	0.00546	CcSEcCtD
Baclofen—Oedema—Mercaptopurine—Crohn's disease	0.00155	0.00541	CcSEcCtD
Baclofen—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.00155	0.0132	CbGpPWpGaD
Baclofen—Breast disorder—Mesalazine—Crohn's disease	0.00155	0.0054	CcSEcCtD
Baclofen—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00154	0.00538	CcSEcCtD
Baclofen—Petechiae—Prednisone—Crohn's disease	0.00152	0.0053	CcSEcCtD
Baclofen—Skin disorder—Mercaptopurine—Crohn's disease	0.0015	0.00526	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—CCR6—Crohn's disease	0.00148	0.0126	CbGpPWpGaD
Baclofen—Influenza—Mesalazine—Crohn's disease	0.00148	0.00517	CcSEcCtD
Baclofen—Dysphagia—Mesalazine—Crohn's disease	0.00148	0.00517	CcSEcCtD
Baclofen—Anorexia—Mercaptopurine—Crohn's disease	0.00148	0.00516	CcSEcCtD
Baclofen—Pneumonia—Azathioprine—Crohn's disease	0.00146	0.00509	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—CCR9—Crohn's disease	0.00144	0.0123	CbGpPWpGaD
Baclofen—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00141	0.00493	CcSEcCtD
Baclofen—Dysuria—Mesalazine—Crohn's disease	0.00138	0.00483	CcSEcCtD
Baclofen—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00137	0.00478	CcSEcCtD
Baclofen—Pollakiuria—Mesalazine—Crohn's disease	0.00137	0.00477	CcSEcCtD
Baclofen—Decreased appetite—Mercaptopurine—Crohn's disease	0.00135	0.00471	CcSEcCtD
Baclofen—Weight increased—Mesalazine—Crohn's disease	0.00135	0.0047	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—GPR65—Crohn's disease	0.00134	0.0114	CbGpPWpGaD
Baclofen—Weight decreased—Mesalazine—Crohn's disease	0.00134	0.00468	CcSEcCtD
Baclofen—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00134	0.00467	CcSEcCtD
Baclofen—Leukocytosis—Prednisone—Crohn's disease	0.00133	0.00464	CcSEcCtD
Baclofen—Pneumonia—Mesalazine—Crohn's disease	0.00133	0.00463	CcSEcCtD
Baclofen—Depression—Mesalazine—Crohn's disease	0.00131	0.00459	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—PTGER4—Crohn's disease	0.0013	0.0111	CbGpPWpGaD
Baclofen—Renal failure—Mesalazine—Crohn's disease	0.0013	0.00453	CcSEcCtD
Baclofen—Sweating—Mesalazine—Crohn's disease	0.00126	0.00442	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—CCR9—Crohn's disease	0.00126	0.0108	CbGpPWpGaD
Baclofen—Haematuria—Mesalazine—Crohn's disease	0.00126	0.00439	CcSEcCtD
Baclofen—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00125	0.00436	CcSEcCtD
Baclofen—Ibuprofen—PTGS2—Crohn's disease	0.00123	0.132	CrCbGaD
Baclofen—Body temperature increased—Mercaptopurine—Crohn's disease	0.00122	0.00428	CcSEcCtD
Baclofen—Rhinitis—Mesalazine—Crohn's disease	0.00119	0.00415	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—MLN—Crohn's disease	0.00117	0.01	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—GPR65—Crohn's disease	0.00117	0.01	CbGpPWpGaD
Baclofen—Mediastinal disorder—Azathioprine—Crohn's disease	0.00117	0.00409	CcSEcCtD
Baclofen—Urinary tract disorder—Mesalazine—Crohn's disease	0.00117	0.00408	CcSEcCtD
Baclofen—Oedema peripheral—Mesalazine—Crohn's disease	0.00117	0.00407	CcSEcCtD
Baclofen—Chills—Azathioprine—Crohn's disease	0.00117	0.00407	CcSEcCtD
Baclofen—Connective tissue disorder—Mesalazine—Crohn's disease	0.00116	0.00406	CcSEcCtD
Baclofen—Arrhythmia—Azathioprine—Crohn's disease	0.00116	0.00406	CcSEcCtD
Baclofen—Urethral disorder—Mesalazine—Crohn's disease	0.00116	0.00405	CcSEcCtD
Baclofen—Alopecia—Azathioprine—Crohn's disease	0.00115	0.00401	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—CCR9—Crohn's disease	0.00115	0.00979	CbGpPWpGaD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00113	0.00965	CbGpPWpGaD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00113	0.00965	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—ACKR2—Crohn's disease	0.00112	0.0096	CbGpPWpGaD
Baclofen—Eye disorder—Mesalazine—Crohn's disease	0.00111	0.00387	CcSEcCtD
Baclofen—Tinnitus—Mesalazine—Crohn's disease	0.0011	0.00386	CcSEcCtD
Baclofen—Cardiac disorder—Mesalazine—Crohn's disease	0.0011	0.00384	CcSEcCtD
Baclofen—Ibuprofen—ALB—Crohn's disease	0.0011	0.118	CrCbGaD
Baclofen—Sepsis—Prednisone—Crohn's disease	0.00108	0.00378	CcSEcCtD
Baclofen—Angiopathy—Mesalazine—Crohn's disease	0.00107	0.00375	CcSEcCtD
Baclofen—Euphoric mood—Prednisone—Crohn's disease	0.00107	0.00374	CcSEcCtD
Baclofen—Mediastinal disorder—Mesalazine—Crohn's disease	0.00107	0.00373	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—GPR65—Crohn's disease	0.00107	0.0091	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—MLN—Crohn's disease	0.00107	0.0091	CbGpPWpGaD
Baclofen—Chills—Mesalazine—Crohn's disease	0.00106	0.00371	CcSEcCtD
Baclofen—Diarrhoea—Mercaptopurine—Crohn's disease	0.00106	0.0037	CcSEcCtD
Baclofen—Ill-defined disorder—Azathioprine—Crohn's disease	0.00105	0.00367	CcSEcCtD
Baclofen—Alopecia—Mesalazine—Crohn's disease	0.00105	0.00365	CcSEcCtD
Baclofen—Thrombophlebitis—Prednisone—Crohn's disease	0.00105	0.00365	CcSEcCtD
Baclofen—Anaemia—Azathioprine—Crohn's disease	0.00104	0.00365	CcSEcCtD
Baclofen—Mental disorder—Mesalazine—Crohn's disease	0.00104	0.00362	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—ACKR2—Crohn's disease	0.00103	0.0088	CbGpPWpGaD
Baclofen—Malaise—Azathioprine—Crohn's disease	0.00102	0.00356	CcSEcCtD
Baclofen—Flatulence—Mesalazine—Crohn's disease	0.00101	0.00355	CcSEcCtD
Baclofen—Dysgeusia—Mesalazine—Crohn's disease	0.00101	0.00353	CcSEcCtD
Baclofen—Back pain—Mesalazine—Crohn's disease	0.000996	0.00348	CcSEcCtD
Baclofen—Vomiting—Mercaptopurine—Crohn's disease	0.000985	0.00344	CcSEcCtD
Baclofen—Injury—Prednisone—Crohn's disease	0.000984	0.00344	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—MLN—Crohn's disease	0.000977	0.00834	CbGpPWpGaD
Baclofen—Rash—Mercaptopurine—Crohn's disease	0.000976	0.00341	CcSEcCtD
Baclofen—Dermatitis—Mercaptopurine—Crohn's disease	0.000976	0.00341	CcSEcCtD
Baclofen—Vision blurred—Mesalazine—Crohn's disease	0.000971	0.00339	CcSEcCtD
Baclofen—Tremor—Mesalazine—Crohn's disease	0.000965	0.00337	CcSEcCtD
Baclofen—Amnesia—Prednisone—Crohn's disease	0.000963	0.00337	CcSEcCtD
Baclofen—Myalgia—Azathioprine—Crohn's disease	0.000963	0.00337	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000956	0.00334	CcSEcCtD
Baclofen—Ill-defined disorder—Mesalazine—Crohn's disease	0.000956	0.00334	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—CCR6—Crohn's disease	0.000953	0.00814	CbGpPWpGaD
Baclofen—Anaemia—Mesalazine—Crohn's disease	0.000952	0.00333	CcSEcCtD
Baclofen—Discomfort—Azathioprine—Crohn's disease	0.000951	0.00332	CcSEcCtD
Baclofen—Malaise—Mesalazine—Crohn's disease	0.000929	0.00325	CcSEcCtD
Baclofen—Vertigo—Mesalazine—Crohn's disease	0.000925	0.00323	CcSEcCtD
Baclofen—Syncope—Mesalazine—Crohn's disease	0.000924	0.00323	CcSEcCtD
Baclofen—Lethargy—Prednisone—Crohn's disease	0.000923	0.00323	CcSEcCtD
Baclofen—Nausea—Mercaptopurine—Crohn's disease	0.00092	0.00322	CcSEcCtD
Baclofen—Infection—Azathioprine—Crohn's disease	0.000917	0.0032	CcSEcCtD
Baclofen—Palpitations—Mesalazine—Crohn's disease	0.00091	0.00318	CcSEcCtD
Baclofen—Loss of consciousness—Mesalazine—Crohn's disease	0.000905	0.00316	CcSEcCtD
Baclofen—Osteoarthritis—Prednisone—Crohn's disease	0.000905	0.00316	CcSEcCtD
Baclofen—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000905	0.00316	CcSEcCtD
Baclofen—Skin disorder—Azathioprine—Crohn's disease	0.000896	0.00313	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—TAGAP—Crohn's disease	0.000893	0.00763	CbGpPWpGaD
Baclofen—Affect lability—Prednisone—Crohn's disease	0.000891	0.00311	CcSEcCtD
Baclofen—Hypertension—Mesalazine—Crohn's disease	0.000889	0.00311	CcSEcCtD
Baclofen—Psychotic disorder—Prednisone—Crohn's disease	0.000884	0.00309	CcSEcCtD
Baclofen—Chest pain—Mesalazine—Crohn's disease	0.000877	0.00307	CcSEcCtD
Baclofen—Myalgia—Mesalazine—Crohn's disease	0.000877	0.00307	CcSEcCtD
Baclofen—Anxiety—Mesalazine—Crohn's disease	0.000874	0.00305	CcSEcCtD
Baclofen—Face oedema—Prednisone—Crohn's disease	0.000873	0.00305	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000871	0.00304	CcSEcCtD
Baclofen—Discomfort—Mesalazine—Crohn's disease	0.000866	0.00303	CcSEcCtD
Baclofen—Hypotension—Azathioprine—Crohn's disease	0.000862	0.00301	CcSEcCtD
Baclofen—Dry mouth—Mesalazine—Crohn's disease	0.000857	0.003	CcSEcCtD
Baclofen—Mood swings—Prednisone—Crohn's disease	0.000857	0.003	CcSEcCtD
Baclofen—Confusional state—Mesalazine—Crohn's disease	0.000847	0.00296	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000841	0.00294	CcSEcCtD
Baclofen—Oedema—Mesalazine—Crohn's disease	0.00084	0.00294	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—PTGER4—Crohn's disease	0.000839	0.00717	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CCR6—Crohn's disease	0.000836	0.00714	CbGpPWpGaD
Baclofen—Infection—Mesalazine—Crohn's disease	0.000835	0.00292	CcSEcCtD
Baclofen—Shock—Mesalazine—Crohn's disease	0.000827	0.00289	CcSEcCtD
Baclofen—Nervous system disorder—Mesalazine—Crohn's disease	0.000824	0.00288	CcSEcCtD
Baclofen—Tachycardia—Mesalazine—Crohn's disease	0.00082	0.00287	CcSEcCtD
Baclofen—Skin disorder—Mesalazine—Crohn's disease	0.000816	0.00285	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—CCR9—Crohn's disease	0.000813	0.00695	CbGpPWpGaD
Baclofen—Hyperhidrosis—Mesalazine—Crohn's disease	0.000813	0.00284	CcSEcCtD
Baclofen—Anorexia—Mesalazine—Crohn's disease	0.000801	0.0028	CcSEcCtD
Baclofen—Muscular weakness—Prednisone—Crohn's disease	0.000798	0.00279	CcSEcCtD
Baclofen—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000797	0.00279	CcSEcCtD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000796	0.0068	CbGpPWpGaD
Baclofen—GABBR2—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000787	0.00673	CbGpPWpGaD
Baclofen—Hypotension—Mesalazine—Crohn's disease	0.000785	0.00275	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—RSPO3—Crohn's disease	0.000781	0.00667	CbGpPWpGaD
Baclofen—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000766	0.00268	CcSEcCtD
Baclofen—Sweating increased—Prednisone—Crohn's disease	0.000762	0.00266	CcSEcCtD
Baclofen—Feeling abnormal—Azathioprine—Crohn's disease	0.00076	0.00266	CcSEcCtD
Baclofen—Insomnia—Mesalazine—Crohn's disease	0.00076	0.00266	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—CCR6—Crohn's disease	0.000759	0.00649	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—GPR65—Crohn's disease	0.000756	0.00646	CbGpPWpGaD
Baclofen—Paraesthesia—Mesalazine—Crohn's disease	0.000755	0.00264	CcSEcCtD
Baclofen—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000755	0.00264	CcSEcCtD
Baclofen—Dyspnoea—Mesalazine—Crohn's disease	0.000749	0.00262	CcSEcCtD
Baclofen—Somnolence—Mesalazine—Crohn's disease	0.000747	0.00261	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—SEL1L—Crohn's disease	0.00074	0.00632	CbGpPWpGaD
Baclofen—Dyspepsia—Mesalazine—Crohn's disease	0.00074	0.00259	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—CCR9—Crohn's disease	0.000739	0.00631	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PTGER4—Crohn's disease	0.000736	0.00629	CbGpPWpGaD
Baclofen—Decreased appetite—Mesalazine—Crohn's disease	0.000731	0.00255	CcSEcCtD
Baclofen—Body temperature increased—Azathioprine—Crohn's disease	0.000729	0.00255	CcSEcCtD
Baclofen—Abdominal pain—Azathioprine—Crohn's disease	0.000729	0.00255	CcSEcCtD
Baclofen—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000726	0.00254	CcSEcCtD
Baclofen—Fatigue—Mesalazine—Crohn's disease	0.000725	0.00253	CcSEcCtD
Baclofen—Erectile dysfunction—Prednisone—Crohn's disease	0.00072	0.00252	CcSEcCtD
Baclofen—Constipation—Mesalazine—Crohn's disease	0.000719	0.00251	CcSEcCtD
Baclofen—Pain—Mesalazine—Crohn's disease	0.000719	0.00251	CcSEcCtD
Baclofen—Weight increased—Prednisone—Crohn's disease	0.000712	0.00249	CcSEcCtD
Baclofen—Weight decreased—Prednisone—Crohn's disease	0.000707	0.00247	CcSEcCtD
Baclofen—Hyperglycaemia—Prednisone—Crohn's disease	0.000705	0.00247	CcSEcCtD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000703	0.00601	CbGpPWpGaD
Baclofen—Depression—Prednisone—Crohn's disease	0.000695	0.00243	CcSEcCtD
Baclofen—Feeling abnormal—Mesalazine—Crohn's disease	0.000693	0.00242	CcSEcCtD
Baclofen—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000687	0.0024	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—GPR65—Crohn's disease	0.000687	0.00587	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CCR9—Crohn's disease	0.000677	0.00578	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PTGER4—Crohn's disease	0.000668	0.00571	CbGpPWpGaD
Baclofen—Urticaria—Mesalazine—Crohn's disease	0.000668	0.00233	CcSEcCtD
Baclofen—Abdominal pain—Mesalazine—Crohn's disease	0.000664	0.00232	CcSEcCtD
Baclofen—Body temperature increased—Mesalazine—Crohn's disease	0.000664	0.00232	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—ACKR2—Crohn's disease	0.000664	0.00567	CbGpPWpGaD
Baclofen—Bradycardia—Prednisone—Crohn's disease	0.000637	0.00223	CcSEcCtD
Baclofen—Diarrhoea—Azathioprine—Crohn's disease	0.000631	0.00221	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—GPR65—Crohn's disease	0.000629	0.00538	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MLN—Crohn's disease	0.000629	0.00538	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—IL3—Crohn's disease	0.000627	0.00536	CbGpPWpGaD
Baclofen—Hallucination—Prednisone—Crohn's disease	0.000623	0.00218	CcSEcCtD
Baclofen—Connective tissue disorder—Prednisone—Crohn's disease	0.000615	0.00215	CcSEcCtD
Baclofen—Dizziness—Azathioprine—Crohn's disease	0.00061	0.00213	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000606	0.00518	CbGpPWpGaD
Baclofen—Asthenia—Mesalazine—Crohn's disease	0.000603	0.00211	CcSEcCtD
Baclofen—Pruritus—Mesalazine—Crohn's disease	0.000595	0.00208	CcSEcCtD
Baclofen—Vomiting—Azathioprine—Crohn's disease	0.000587	0.00205	CcSEcCtD
Baclofen—Eye disorder—Prednisone—Crohn's disease	0.000585	0.00205	CcSEcCtD
Baclofen—Rash—Azathioprine—Crohn's disease	0.000582	0.00203	CcSEcCtD
Baclofen—Dermatitis—Azathioprine—Crohn's disease	0.000581	0.00203	CcSEcCtD
Baclofen—Flushing—Prednisone—Crohn's disease	0.000581	0.00203	CcSEcCtD
Baclofen—Headache—Azathioprine—Crohn's disease	0.000578	0.00202	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—TAGAP—Crohn's disease	0.000576	0.00492	CbGpPWpGaD
Baclofen—Diarrhoea—Mesalazine—Crohn's disease	0.000575	0.00201	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000574	0.0049	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000574	0.0049	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL3—Crohn's disease	0.000569	0.00486	CbGpPWpGaD
Baclofen—Angiopathy—Prednisone—Crohn's disease	0.000568	0.00199	CcSEcCtD
Baclofen—Arrhythmia—Prednisone—Crohn's disease	0.000559	0.00195	CcSEcCtD
Baclofen—Dizziness—Mesalazine—Crohn's disease	0.000556	0.00194	CcSEcCtD
Baclofen—Alopecia—Prednisone—Crohn's disease	0.000553	0.00193	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—RASGRP1—Crohn's disease	0.000551	0.0047	CbGpPWpGaD
Baclofen—Mental disorder—Prednisone—Crohn's disease	0.000548	0.00192	CcSEcCtD
Baclofen—Nausea—Azathioprine—Crohn's disease	0.000548	0.00192	CcSEcCtD
Baclofen—Malnutrition—Prednisone—Crohn's disease	0.000545	0.00191	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—CCR6—Crohn's disease	0.000539	0.0046	CbGpPWpGaD
Baclofen—Vomiting—Mesalazine—Crohn's disease	0.000534	0.00187	CcSEcCtD
Baclofen—Rash—Mesalazine—Crohn's disease	0.00053	0.00185	CcSEcCtD
Baclofen—Dermatitis—Mesalazine—Crohn's disease	0.000529	0.00185	CcSEcCtD
Baclofen—Headache—Mesalazine—Crohn's disease	0.000527	0.00184	CcSEcCtD
Baclofen—Vision blurred—Prednisone—Crohn's disease	0.000514	0.0018	CcSEcCtD
Baclofen—GABBR1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000507	0.00433	CbGpPWpGaD
Baclofen—Ill-defined disorder—Prednisone—Crohn's disease	0.000506	0.00177	CcSEcCtD
Baclofen—Anaemia—Prednisone—Crohn's disease	0.000504	0.00176	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—RSPO3—Crohn's disease	0.000503	0.0043	CbGpPWpGaD
Baclofen—Agitation—Prednisone—Crohn's disease	0.000501	0.00175	CcSEcCtD
Baclofen—Nausea—Mesalazine—Crohn's disease	0.000499	0.00175	CcSEcCtD
Baclofen—Malaise—Prednisone—Crohn's disease	0.000491	0.00172	CcSEcCtD
Baclofen—Vertigo—Prednisone—Crohn's disease	0.00049	0.00171	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—CCR6—Crohn's disease	0.000489	0.00418	CbGpPWpGaD
Baclofen—Syncope—Prednisone—Crohn's disease	0.000489	0.00171	CcSEcCtD
Baclofen—Loss of consciousness—Prednisone—Crohn's disease	0.000479	0.00167	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—SEL1L—Crohn's disease	0.000477	0.00408	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—CXCL8—Crohn's disease	0.000477	0.00407	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000474	0.00405	CbGpPWpGaD
Baclofen—Convulsion—Prednisone—Crohn's disease	0.000472	0.00165	CcSEcCtD
Baclofen—Hypertension—Prednisone—Crohn's disease	0.00047	0.00164	CcSEcCtD
Baclofen—Myalgia—Prednisone—Crohn's disease	0.000464	0.00162	CcSEcCtD
Baclofen—Anxiety—Prednisone—Crohn's disease	0.000462	0.00162	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000461	0.00161	CcSEcCtD
Baclofen—Discomfort—Prednisone—Crohn's disease	0.000458	0.0016	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CCR6—Crohn's disease	0.000448	0.00383	CbGpPWpGaD
Baclofen—Oedema—Prednisone—Crohn's disease	0.000445	0.00155	CcSEcCtD
Baclofen—Infection—Prednisone—Crohn's disease	0.000442	0.00154	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—IL2RA—Crohn's disease	0.000439	0.00375	CbGpPWpGaD
Baclofen—Shock—Prednisone—Crohn's disease	0.000438	0.00153	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CCR9—Crohn's disease	0.000436	0.00373	CbGpPWpGaD
Baclofen—Nervous system disorder—Prednisone—Crohn's disease	0.000436	0.00152	CcSEcCtD
Baclofen—Tachycardia—Prednisone—Crohn's disease	0.000434	0.00152	CcSEcCtD
Baclofen—Skin disorder—Prednisone—Crohn's disease	0.000432	0.00151	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—PTGER4—Crohn's disease	0.000431	0.00368	CbGpPWpGaD
Baclofen—Hyperhidrosis—Prednisone—Crohn's disease	0.00043	0.0015	CcSEcCtD
Baclofen—Anorexia—Prednisone—Crohn's disease	0.000424	0.00148	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—RBX1—Crohn's disease	0.000406	0.00347	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GPR65—Crohn's disease	0.000406	0.00347	CbGpPWpGaD
Baclofen—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000405	0.00142	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000404	0.00345	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—IL3—Crohn's disease	0.000404	0.00345	CbGpPWpGaD
Baclofen—Insomnia—Prednisone—Crohn's disease	0.000402	0.00141	CcSEcCtD
Baclofen—Paraesthesia—Prednisone—Crohn's disease	0.000399	0.0014	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—IL2RA—Crohn's disease	0.000399	0.00341	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PTGER4—Crohn's disease	0.000395	0.00337	CbGpPWpGaD
Baclofen—Dyspepsia—Prednisone—Crohn's disease	0.000391	0.00137	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000391	0.00334	CbGpPWpGaD
Baclofen—Decreased appetite—Prednisone—Crohn's disease	0.000387	0.00135	CcSEcCtD
Baclofen—Fatigue—Prednisone—Crohn's disease	0.000383	0.00134	CcSEcCtD
Baclofen—Constipation—Prednisone—Crohn's disease	0.00038	0.00133	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—IL3—Crohn's disease	0.000367	0.00313	CbGpPWpGaD
Baclofen—Feeling abnormal—Prednisone—Crohn's disease	0.000366	0.00128	CcSEcCtD
Baclofen—Gastrointestinal pain—Prednisone—Crohn's disease	0.000364	0.00127	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000357	0.00305	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—UBE2D1—Crohn's disease	0.000356	0.00304	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000355	0.00303	CbGpPWpGaD
Baclofen—Urticaria—Prednisone—Crohn's disease	0.000353	0.00124	CcSEcCtD
Baclofen—Body temperature increased—Prednisone—Crohn's disease	0.000352	0.00123	CcSEcCtD
Baclofen—Abdominal pain—Prednisone—Crohn's disease	0.000352	0.00123	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—RIPK2—Crohn's disease	0.000345	0.00295	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL3—Crohn's disease	0.000336	0.00287	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—RASGRP1—Crohn's disease	0.000325	0.00278	CbGpPWpGaD
Baclofen—Asthenia—Prednisone—Crohn's disease	0.000319	0.00112	CcSEcCtD
Baclofen—Pruritus—Prednisone—Crohn's disease	0.000315	0.0011	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—CXCL8—Crohn's disease	0.000307	0.00262	CbGpPWpGaD
Baclofen—Diarrhoea—Prednisone—Crohn's disease	0.000304	0.00106	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—JAK2—Crohn's disease	0.000295	0.00252	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SOCS1—Crohn's disease	0.000295	0.00252	CbGpPWpGaD
Baclofen—Dizziness—Prednisone—Crohn's disease	0.000294	0.00103	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CCR6—Crohn's disease	0.000289	0.00247	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000283	0.00242	CbGpPWpGaD
Baclofen—Vomiting—Prednisone—Crohn's disease	0.000283	0.000989	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—TYK2—Crohn's disease	0.000281	0.0024	CbGpPWpGaD
Baclofen—Rash—Prednisone—Crohn's disease	0.00028	0.00098	CcSEcCtD
Baclofen—Dermatitis—Prednisone—Crohn's disease	0.00028	0.000979	CcSEcCtD
Baclofen—Headache—Prednisone—Crohn's disease	0.000279	0.000974	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—CXCL8—Crohn's disease	0.000269	0.0023	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—JAK2—Crohn's disease	0.000268	0.00229	CbGpPWpGaD
Baclofen—Nausea—Prednisone—Crohn's disease	0.000264	0.000923	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—RBX1—Crohn's disease	0.000261	0.00223	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL2RA—Crohn's disease	0.000257	0.0022	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SMAD3—Crohn's disease	0.000254	0.00217	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTGER4—Crohn's disease	0.000254	0.00217	CbGpPWpGaD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000253	0.00216	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CXCL8—Crohn's disease	0.000245	0.00209	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL2RA—Crohn's disease	0.000236	0.00201	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—UBE2D1—Crohn's disease	0.000229	0.00196	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RIPK2—Crohn's disease	0.000222	0.0019	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL3—Crohn's disease	0.000217	0.00185	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RASGRP1—Crohn's disease	0.00021	0.00179	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—JAK2—Crohn's disease	0.00019	0.00163	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SOCS1—Crohn's disease	0.00019	0.00162	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—TYK2—Crohn's disease	0.000181	0.00155	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000174	0.00148	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—JAK2—Crohn's disease	0.000173	0.00148	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TYK2—Crohn's disease	0.000166	0.00142	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SMAD3—Crohn's disease	0.000164	0.0014	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—JAK2—Crohn's disease	0.000158	0.00135	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CXCL8—Crohn's disease	0.000158	0.00135	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL2RA—Crohn's disease	0.000152	0.0013	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CXCL8—Crohn's disease	0.000145	0.00123	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL6—Crohn's disease	0.000137	0.00117	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000129	0.0011	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—STAT3—Crohn's disease	0.000116	0.000993	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TYK2—Crohn's disease	0.000107	0.000914	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—JAK2—Crohn's disease	0.000102	0.000872	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CXCL8—Crohn's disease	9.31e-05	0.000796	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL6—Crohn's disease	8.86e-05	0.000757	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL6—Crohn's disease	8.12e-05	0.000694	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—STAT3—Crohn's disease	7.49e-05	0.00064	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL6—Crohn's disease	5.23e-05	0.000447	CbGpPWpGaD
